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Abstract  19 
In this study the feasibility of a LLE-GC-EI-MS method for the analysis of 43 phenolic acids 20 
belonging to different chemical structure families which have been described in the literature as 21 
microbial-derived metabolites after consumption of dietary polyphenols was proved. In addition, 22 
the method was applied for the characterisation of phenolic metabolites resulting from the 23 
incubation, in anaerobic conditions, of a commercial grape seed extract (GSE) and their 24 
corresponding flavan-3-ol monomeric (GSE-M) and oligomeric (GSE-O) fractions with human 25 
faeces from healthy volunteers (n=3). The method showed average values of repeatability and 26 
reproducibility of 5.0 % and 6.3 %, respectively, adequate and low detection (1.8-30.8 μg L-1) 27 
and quantification limits (6.0-102.8 μg L-1) and good recovery values (95 %, as average value). 28 
A total of 27 phenolic acids were identified in the faecal solutions after incubation with the 29 
grape seed extracts. In general, faecal samples incubated with GSE and GSE-M (monomeric 30 
fraction) yield a higher formation of phenolic acids compared to the samples incubated with the 31 
oligomer fraction (GSE-O).  32 
 33 
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Introduction 36 
 37 
Flavanols or flavan-3-ols are a unique class of flavonoids that are present as monomers, 38 
oligomers and polymers in the human diet. Oligomers and polymers are called 39 
proanthocyanidins or condensed tannins, and they are some of the most abundant phenolic 40 
compounds in some foods such as cacao, tea and wine (Gu et al., 2004). They are mainly made 41 
up of (epi)catechin or (epi)gallocatechin units that are known as procyanidins or 42 
prodelphinidins, respectively (Donovan, Manach, Rios, Morand, Scalbert & Rémésy, 2002). 43 
 44 
The most common subclass of proanthocyanidins is the procyanidins. Their monomeric 45 
units [(+)-catechin and (-)-epicatechin)] are linked through a C4-C8 or C4-C6 bond (B-Type), 46 
which can coexist with an additional C2-O-C7 bond (A-Type). Absorption of procyanidins after 47 
food intake has been reported in several earlier studies (Donovan et al., 2002; Groenewoud & 48 
Hundt, 1986; Van'T Slot, Mattern, Rzeppa, Grewe & Humpf, 2010) and it is known that only 49 
procyanidin dimers are believed to be absorbed intact, although with lower efficiency than the 50 
monomeric units (Appeldoorn, Vincken, Aura, Hollman & Gruppen, 2009). Due to the low 51 
absorption of intact procyanidins, gut microbial metabolism might play an important role. In 52 
fact, monomeric flavan-3-ols are known to be degraded in the gut by colonic microbiota into 53 
several phenolic acids with varying hydroxylation patterns, namely, phenylvaleric, 54 
phenylpropionic, phenylacetics, benzoic and hippuric acids (Ríos et al., 2003), and other non-55 
phenolic catabolites (Das & Griffiths, 1969). These metabolites may selectively influence the 56 
growth of intestinal bacteria (both beneficial and pathogenic bacteria) (Cueva et al., 2010), thus 57 
the consumption of foods rich in procyanidins, like wine, might have a direct impact in human 58 
gut health (Stoupi, Williamson, Drynan, Barron & Clifford, 2010). 59 
 60 
In trying to know more in deep about the absorption and metabolism of these 61 
procyanidins, in vitro fermentations can be a useful tool to carry out these studies because there 62 
are easier to perform than in vivo studies. They have the additional advantage that relatively 63 
high concentrations of metabolites, not yet affected by absorption and metabolism, are present, 64 
which facilitates detection (Appeldoorn et al., 2009). In addition, it has been indicated, that 65 
studies performed with animals may result in substantially different bioconversions compared to 66 
humans, as has been shown for (+)-catechin and (-)-epicatechin (Scalbert, Manach, Morand, 67 
Rémésy & Jiménez, 2005; Williams, Eyton-Jones, Farnworth, Gallagher & Provan, 2002). 68 
 69 
 Therefore, the identification and quantification of phenolic metabolites in physiological 70 
samples is becoming an outstanding task in different fields, such as food science, nutrition and 71 
clinic. The availability of sensitive and roughness analytical tools is an aspect of great 72 
importance for their characterization. Although there are many studies based on the use of 73 
Liquid Cromatography (LC) coupled to mass spectrometry techniques (MS) for the analysis of 74 
these compounds (Appeldoorn et al., 2009; Aura et al., 2005; Gonthier et al., 2006; Gonthier, 75 
Rios, Verny, Rémésy & Scalbert, 2003b; Urpí-Sarda et al., 2009), Gas Chromatography-MS 76 
(GC-MS) is a complementary analytical technique that can be also adequate for their analysis 77 
(Gonthier et al., 2003a; Rechner et al., 2004; Ríos et al., 2003). Recently, Grün and collaborators 78 
(Grün et al., 2008) have published a method for the analysis of phenolic acids in physiological 79 
samples based on the use of liquid-liquid extraction (LLE). Since then, the use of this isolation 80 
technique combined with GC-MS analysis is increasing (Gross et al., 2010; Peters, Janssen & 81 
Vivo-Truyols, 2010; van Dorsten, Grün, van Velzen, Jacobs, Draijer & van Duynhoven, 2010). 82 
However, as far as we know, none study  in the scientific literature has been devoted to show the 83 
analytical performance of this method and its feasibility for a large group of phenolic acids 84 
belonging to different chemical structure families which could be present in physiological 85 
samples. 86 
 87 
Therefore, the aim of the present work has been to show the analytical performance of 88 
the LLE-GC-EI-MS for the quantification of a wide range of phenolic metabolites belonging to 89 
different phenolic acid groups that might come from the degradation of dietary polyphenols by 90 
gut microbiota, and to apply it for the characterisation of the phenolic metabolites resulting from 91 
the incubation, in anaerobic conditions, of a commercial grape seed extract and their 92 
corresponding flavan-3-ol monomeric and oligomeric fractions with faecal samples from three 93 
healthy volunteers. 94 
 95 
 96 
2. Materials and methods 97 
 98 
2.1. Chemicals, reagents and standard solutions 99 
 100 
For this study, 43 phenolic compounds which belong to seven different chemical 101 
structure families that have been described in the literature as phenolic microbial-derived 102 
metabolites were selected (Table 1). Phenolic standards were provided by Sigma-Aldrich 103 
Chemical Co (St. Louis, MO), Phytolab (Vestenbergsgreuth, Germany) and Extrasynthèse 104 
(Genay, France) and had purity greater than 98 %. A standard solution formed with the 43 105 
compounds at a concentration of 250 mg L
-1
 was prepared in ethanol (Panreac, Spain). In order 106 
to determine the performance characteristics of the method, working solutions were prepared by 107 
diluting different amounts of the standard solution in ethanol. The concentration of the working 108 
solutions ranged between 0.1-25 mg L
-1
. 109 
 110 
2.2 Liquid-liquid extraction (LLE) 111 
 112 
The liquid-liquid extraction procedure was basically performed as described by Grün et 113 
al (2008). To 500 μL of sample (aqueous solution of 43 phenolic compounds or faecal samples 114 
spiked with the same compounds), 65 μL of 1M hydrochloric acid (Prolabo, France)) were 115 
added for acidifying the samples (pH 2-3) prior to the extraction. After the addition of the 116 
internal standard (50 μL of 100 μg mL-1 trans-cinnamic acid-d7 (Sigma-Aldrich, Switzerland) in 117 
1:1 methanol/water (v/v)), the samples were kept at 4 ºC for 10 min. Two mL of ethyl acetate 118 
were added, the samples were vortexed for 30 s, and centrifuged at 3000 g for 10 min. The 119 
supernatants were transferred and the extraction was repeated twice. The resulting extracts were 120 
combined and concentrated under nitrogen stream. Samples were further dried by the 121 
subsequent addition and evaporation of 1 mL of dichloromethane. To the samples, 100 μL of 122 
BSTA/TMCS (N,O-Bis(trimethylsilyl)trifluoroacetamide with 10 % trimethylchlorosilane) 123 
(Sigma-Aldrich, Switzerland) was added for the formation of the corresponding silyl-derived 124 
compounds. The samples were incubated at 90 ºC for 30 min. After cooling down to room 125 
temperature, 100 μL of hexane were added to 100 μL of the derivatized samples and the 126 
mixtures were vortex-mixed. Then, GC-MS analysis was carried out. Five levels of 127 
concentrations of each phenolic acid (0.1, 1, 5, 10, 25 mg L
-1
) were tested in duplicate. 128 
 129 
2.3 Gas chromatography-Mass spectrometry analysis 130 
 131 
An Agilent 6890N GC system (Agilent, Palo Alto, CA) with a split/splitless injector and 132 
interfaced with an Agilent 5973N mass spectrometer was used for sample analysis. The injector 133 
was set at 280 ºC. An Agilent MSD ChemStation Software (E.02.00.493 version) was used to 134 
control the system. For separation, an HP-5MS fused silica capillary column (30 m x 0.25 mm x 135 
0.25 μm) Quadrex Co. (Woodbridge, CT) was used. Helium was the carrier gas (1 mL min-1). 136 
One μL of the sample was injected in split mode at a split ratio of 20:1. The GC conditions were 137 
as follows: initial temperature of 45 ºC for 1 min to 100 ºC (held for 5.5 min) at 10 ºC/min. 138 
Then, the temperature was increased up to 300 ºC at 7.5 ºC/min and held for 2.5 min giving a 139 
total run time of 41 min. 140 
 141 
For the MS system, the temperatures of the transfer line, quadrupole and ionization 142 
source were 270, 150 and 230 ºC respectively; electron impact mass spectra were recorded at 143 
70eV ionization voltages and the ionization current was 10 μA. The acquisitions were performed 144 
in scan mode (from 35 to 450 amu). Peak identification was carried out by analogy of mass 145 
spectra with those of the mass library (Wiley 6.0 and Nist 2.0) and comparing the calculated 146 
retention times and the mass spectra with those corresponding to commercial standards. 147 
Quantitative data were obtained by calculating the relative areas (area of the quantification ion 148 
of the phenolic compound / area of the quantification ion of the internal standard (trans-149 
cinnamic acid-d7). Calibration curves representing relative areas of quantification ions vs. 150 
concentration were built for quantification purposes. 151 
 152 
2.4 Fermentation of phenolic extracts by faecal microorganisms  153 
 154 
 Faecal samples were collected from three separate individuals (females). All volunteers 155 
were in good health, they were nonsmokers, aged from 25 to 30 years, had not ingested 156 
antibiotics for at least 6 months before the study, and had no history of any gastrointestinal 157 
disease. Samples were collected, on site, on the day of the experiment and were used 158 
immediately. The in vitro batch culture fermentations were basically performed as described by 159 
Tzounis and collaborators (Tzounis et al., 2008). The samples were diluted 1:10 (w/v) with 160 
anaerobic phosphate buffer (1 M; pH 7.4) and homogenized in a stomacher for 2 min. Resulting 161 
faecal slurries from each individual (i.e. faecal samples were not pooled) were used to inoculate 162 
the batch-culture vessels. 163 
 164 
Three commercial extracts kindly supplied by Dr. Piriou (Les Dérives Resiniques & 165 
Terpéniques, S.A., France) were used in this study: a grape seed extract (Vitaflavan®) (GSE) 166 
and two rich-monomeric (GSE-M) and rich-oligomeric (GSE-O) fractions obtained from 167 
Vitaflavan®. According to the producer, the monomeric fraction contained around 58 % 168 
monomers and 42 % procyanidins whereas the oligomeric fraction contained around 7 % 169 
monomers and 93 % procyanidins. More detailed composition of the grape seed extract and their 170 
fractions is reported in Monagas, Hernández-Ledesma, Garrido, Martín-Álvarez, Gómez-171 
Cordovés & Bartolomé, (2005).    172 
 173 
Batch-culture fermentation vessels (300 mL volume; one vessel per treatment group) 174 
were sterilised and filled with 135 mL basal nutrient medium (peptone water (2 g L
-1
), yeast 175 
extract (2 g L
-1
), NaCl (0.1 g L
-1
), K2HPO4 (0.04 g L
-1
), KH2PO4 (0.04 g L
-1
), NaHCO3 (2 g L
-1
), 176 
MgSO4.7H2O (0.01 g L
-1
), CaCl2.6H2O (0.01 g L
-1
), Tween 80 (2 mL L
-1
), haemin (50 mg L
-1
), 177 
vitamin K1 (10 mL L
-1
), L-cysteine (0.5 g L
-1
), bile salts (0.5 g L
-1
), resazurin (1 mg L
-1
) and 178 
distilled water. The pH of the basal medium was adjusted to 7 and autoclaved before dispensing 179 
it into the vessels. Medium was then gassed overnight with O2-free N2. Before the addition of 180 
faecal slurry samples, the temperature of the basal nutrient medium was set at 37 ºC by using a 181 
circulating water-bath and the pH was maintained at 6.8, using an Electrolab pH controller, in 182 
order to mimic conditions located in the distal region of the human large intestine (anaerobic; 37 183 
ºC; pH about 6.8). Vessels inoculated with 15 mL of faecal slurry (1:10, w/v) and with the three 184 
extracts were tested. As a control, incubations with human faecal slurries were carried out 185 
without the addition of any extract. Samples were collected at different times (30 minutes and 186 
10 hours). Prior to analysis, the samples were centrifuged at 13000 rpm for 10 min at room 187 
temperature and the supernatant was passed through 0.22 μm PVDF filters (OlimPeak, 188 
Tecknokroma). The supernatant was stored at -80 ºC until the extraction.  189 
 190 
  191 
2.6 Statistical analysis 192 
 193 
The statistical methods used for the data analysis were: Linear Regression to establish 194 
the calibration curves of each phenolic compound and the Lack of Fit test to judge the adequacy 195 
of the models; Minimal Differences Tests (LSD) to check differences in mean and Cluster 196 
Analysis to search how the samples are grouped. Statgraphics Centurion XV, version 15.2 197 
(2006, Statistical Graphics Corporation, Manugistics, Inc., MD, www.statgraphics.com) and 198 
Statistica of Windows, version 7.1 (StatSoft Inc., Tulsa, Ok 74104, USA, www.statsoft.com9) 199 
were used for data processing. 200 
 201 
3. Results and discussion 202 
 203 
3.1 Linear regressions 204 
 205 
Data about retention times, molecular masses and characteristics ions used for 206 
quantitative analysis of the 43 phenolic compounds and the internal standard (IS) are reported in 207 
Table 1. For each compound, a linear regression of the relative area (area of the quantification 208 
ion of the phenolic compound / area of the quantification ion of the internal standard) versus 209 
concentration was calculated to determine the linearity of the analytical method, using two 210 
replicates of the aqueous solutions composed by the mix of 43 phenolic compounds at five 211 
levels of concentration (0.1, 1, 5, 10 and 25 mg L
-1
). These concentration levels covered the 212 
concentration ranges expected for the phenolic compounds found in physiological samples 213 
(Grün et al., 2008). To judge the adequacy of the linear models, the F-ratio for lack of fit was 214 
calculated (Massart, 1990). The regression results and the linear ranges are shown in Table 2. 215 
As can be seen, the linear ranges were in general quite wide for most of the compounds. For 216 
most of the compounds they were between 0.1-25 mg L
-1
 except for p-coumaric, 4-217 
hydroxymandelic and 4-hydroxy-3-methoxy mandelic acids that showed a narrow range 218 
between 0.1-10 mg L
-1
, and for the acids, phenylacetic, 4-methoxyphenylacetic and 4-219 
hydroxyhippuric acids, which were between 1-25 mg L
-1
. 220 
 221 
Most of the phenolic compounds belonging to the phenylpropionic, phenylacetic, 222 
cinnamic, mandelic and benzoic acids showed a good linearity, as it can be seen by checking the 223 
determination coefficients (R
2
), which in general showed values > 99 % (Table 2). However, 224 
other compounds, such as 4-hydroxyhippuric acid, catechol/pyrocatechol, phloroglucinol and 225 
pyrogallol showed lower R
2
 values, which could be related to their lower molecular weight and 226 
therefore their losses during the derivatization step. In addition, the residual standard deviation 227 
expressed as a percentage of the mean value (CV %) was lower than 15 % for most of the 228 
phenolic compounds studied, which showed the adequacy of the calculated regressions models 229 
(data not shown). 230 
 231 
3.2. Analytical quality of the LLE-GC-EI-MS method 232 
 233 
3.2.1 Precision 234 
 235 
The intra-day method repeatability was determined by analyzing in triplicate and in the 236 
same day the aqueous solution containing the 43 phenolic acids and the internal standard. 237 
Results were expressed as relative standard deviation (RSD) and they are shown in Table 3.  238 
Relative standard deviations (RSD) ranged between 0.5 to 14.9 %, except for 4-239 
hydroxymandelic acid, which showed an RSD of 16.0 %. In fact, mandelic acids showed the 240 
highest RSD values, while phenylpropionic and phenylacetic acids exhibited the lowest.  The 241 
average value for all compounds was 5.0 %. The inter-day method reproducibility was 242 
determined in the same way but analyses were performed in three different days. The RSD for 243 
all the phenolic compounds ranged between 2.1 % for gallic acid and 14.2 % for 4-244 
hydroxymandelic acid. The average value for all compounds was above 6.3 %, except for p-245 
coumaric acid, which exhibited RSD of 29.2 %.  246 
 247 
 248 
3.2.2 Limits of detection (LOD) and quantification (LOQ) 249 
 250 
The LOD and LOQ were calculated as the lowest concentration yielding a signal-to-251 
noise ratio of at least 3:1 and 10:1, respectively, and were determined for the 43 phenolic acid 252 
standards in a faecal sample spiked with the phenolic mixture at low concentration (1 mg L
-1
). 253 
The LOD values ranged between 1.81 μg L-1 for 4-hydroxy-3-methoxy-mandelic acid to 30.84 254 
μg L-1 for trimethoxycinnamic acid (Table 3). The lowest values corresponded to mandelic acids 255 
and the highest to phenylacetic acids. In addition, the LOQ ranged from 6.02 to 102.81 μg L-1 256 
for 4-hydroxy-3-methoxy-mandelic and trimethoxycinnamic acids, respectively. Mandelic acids 257 
showed the lowest values (6.02 to 28.34 μg L-1) and phenylacetic acids showed the highest 258 
values (30.38 to 93.44 μg L-1). These values were low enough to use the LLE-GC-EI-MS 259 
method for the quantification of all the studied analytes in faecal samples (Gill et al., 2010; 260 
Jenner, Rafter & Halliwell, 2005). 261 
 262 
3.2.3 Recovery  263 
 264 
Extraction recovery was calculated after spiking faecal samples from the same individual 265 
at two levels of concentration (1 and 10 mg L
-1
) with the mixture of 43 phenolic acids plus the 266 
internal standard. All analyses were carried out in duplicate. Recovery average obtained for all 267 
the phenolic compounds was 95 % (Table 3), which showed a low effect of the matrix sample 268 
on the phenolic acid analysis by using the proposed methodology. Differences in the recovery 269 
between the different phenolic acid families were observed. Phenylpropionic, phenylacetic and 270 
benzoic acids showed higher recovery values compared to cinnamic and mandelic acids. 271 
Exceptionally, some compounds such as phloroglucinol and pyrogallol showed very low or very 272 
high recovery values respectively. The low recovery of phloroglucinol could be associated to the 273 
strong interaction of this compound with the matrix sample, because of their low affinity by the 274 
extraction solvent. 275 
 276 
 277 
3.3. Application of LLE-GC-EI-MS method to faecal samples fermented with three commercial 278 
grape seed phenolic extracts  279 
 280 
 The LLE-GC-EI-MS method was applied to know the phenolic metabolites produced 281 
from the degradation of three types of phenolic grape seed extracts by faecal microbiota from 282 
three individuals. The extracts essayed were the whole grape extract (GSE) and its 283 
corresponding purified fractions: rich in monomers (GSE-M) and in oligomers (GSE-O). 284 
Moreover, control samples (C-S), consisting in the faeces of each individual without the 285 
addition of phenolic extracts were also analyzed.  The essays were performed in batch culture 286 
systems, and the samples for phenolic metabolites analysis were collected from the in vitro 287 
fermentation systems after 30 minutes and 10 hours of incubation.  288 
 289 
Figure 1 shows an example of the chromatograms corresponding to the reference phenolic 290 
compounds (Figure 1a) and to the phenolic compounds identified in a faecal sample incubated 291 
with the whole grape extract (GSE) and analyzed after 30 minutes of incubation (Figure 1b).  292 
From the 43 phenolic compounds essayed, 27 were identified in the faecal samples but only 17 293 
compounds were above the calculated limit of quantification (Table 4). The highest 294 
concentration values corresponded to the phenylpropionic acids (1.65 mg L
-1 
in average), 295 
phenylacetic acids (1.31 mg L
-1
) and gallic acid (1.49 mg L
-1
). Benzoic acids (except gallic 296 
acid), showed the lowest concentration values (0.18 mg L
-1
). This is in agreement with Gross 297 
and collaborators (Gross et al., 2010), who found phenylpropionic and phenylacetic acids and 298 
their corresponding hydroxylated derivatives as the major metabolites produced from 299 
wine/grape polyphenols by faecal microbiota while benzoic acids were found in lower amounts. 300 
On the other hand, although some mandelic and cinnamic acids (mandelic, 4-hydroxymandelic, 301 
ferulic acid, among others) were identified in the samples, they could not be quantifying because 302 
they gave very low responses, bellow the calculated LOQ. Some mandelic acids are known 303 
urinary metabolites resulting from different dietary components. For example, 4-304 
hydroxymandelic acid is a natural occurring metabolite from the degradation of tyramine and/or 305 
other similar biogenic amines (van Dorsten et al., 2010). But recently, and using a metabolomic 306 
approach, this acid has been found as a strong urinary marker for the intake of polyphenols from 307 
wine and grape juice (van Dorsten et al., 2010). In the present work, the detection of 4-308 
hydroxymandelic acid in the fermented samples with grape polyphenols extracts confirms its 309 
formation by gut-microbial degradation. 310 
 311 
 The influence of the type of polyphenol extract in the formation of phenolic metabolites 312 
can be evidenced when performing a cluster analysis. Figure 2 shows the dendrogram obtained 313 
after applying this treatment to the data. Herein, is possible clearly distinguishing between two 314 
groups of samples. The first one included all the control samples (C-S) and most of the faecal 315 
samples incubated with the polyphenol fraction rich in oligomeric procyanidins (GSE-O). The 316 
second group contained the faecal samples supplemented with the whole polyphenol fraction 317 
(GSE) and those incubated with the fraction with higher monomer content (GSE-M). These 318 
results seemed to indicate a similar behaviour induced by the whole grape extract and the 319 
purified monomeric fraction compared to the control and the oligomeric fraction. 320 
 321 
 The statistical test of least significant difference (LSD test) was also applied to compare 322 
the means corresponding to the concentration of phenolic metabolites detected in the four types 323 
of faecal systems (controls and faecal samples fermented with the three types of polyphenol 324 
extracts) (Table 4). As can be seen, six metabolites showed differences depending on the type of 325 
polyphenol extract essayed. Some of them, (e.g. 4-hydroxybenzoic acid, phloroglucinol, vanillic 326 
acid) showed lower values in the control samples compared to the samples incubated with the 327 
polyphenolic extracts, which shows the ability of human faecal microbiota to degrade grape 328 
seeds polyphenols. In addition, others compounds such as catechol were detected in the samples 329 
supplemented with the polyphenol extracts but absent in the control sample.  330 
 331 
 Nonetheless, for some compounds, the concentrations calculated in the samples 332 
supplemented with the polyphenol grape extracts did not increase, or they were even higher in 333 
the control samples. Compounds such as benzoic acid, phenyl acetic acid, phenylpropionic acid, 334 
4-hydroxyphenyl acetic and 4-hydroxyphenylpropionic were already present in the faecal 335 
samples without extract addition (C-S) likely because of the bioconversion of other polyphenol 336 
sources from the diet of each individual. The lower amount of these metabolites detected in the 337 
samples supplemented with the polyphenol extracts could be due to the inhibition produced by 338 
the own extracts in the metabolic transformation of these compounds by the gut microbiota. The 339 
inhibition ability of some diet polyphenols on specific gut microorganisms has been recently 340 
shown (Cueva et al., 2010). 341 
 In addition, Table 4 shows that faecal samples incubated with the whole extract (GSE), 342 
and with the monomeric fraction (GSE-M) yield, in general, a higher formation of some 343 
phenolic acids compared to the samples incubated with the oligomeric rich extract (GSE-O). 344 
These compounds were phloroglucinol, vanillic acid, protocatechuic and gallic acids, among 345 
others. These results seem to indicate that the monomers are likely more accessible to gut 346 
microbiota than the polymeric procyanidins. The bioconversion of procyanidin monomers 347 
(catechin and epicatechin) in in vitro systems to some phenolic metabolites such as 348 
hydroxyphenylpropionic or hydroxyphenylvaleric acids derivatives has been already shown 349 
(Aura, 2008). Our results are indeed in agreement with other published works in which a 350 
decrease in the yield of formation of phenolic metabolites from procyanidins by gut microbiota 351 
with an increase in the degree of polymerization has been observed (Deprez et al., 2000; 352 
Gonthier et al., 2003b; Jenner et al., 2005; Ríos et al., 2003). 353 
 354 
It was also observed some compounds exhibiting significant differences in their 355 
concentration according to the type of extract added. While some of them increased in their 356 
concentration, other decreased over time. For example, the concentration of protocatechuic 357 
decreased with an increase in the incubation time. However, the concentration of other 358 
compounds such as phloroglucinol, increased after 600 minutes (10 hours) of incubation. It is 359 
known that this metabolite comes from quercetin (Aura, 2008) but also gallic acid can be 360 
degraded to pyrogallol and it can be further degraded via phloroglucinol to butyrate and acetate 361 
(Gross et al., 2010). Therefore, an increase in the incubation time might promote its degradation 362 
by gut bacteria (Braune, Engst & Blaut, 2005). Nonetheless, it is important to underline, that the 363 
incubation times selected for this study could not be optimal for monitoring the formation of 364 
phenolic metabolites and more samplings points at different incubation times would be 365 
necessary to see the influence of this factor. Moreover, differences in the composition of the 366 
extract, or interindividual differences in microbiota performance may also affect the 367 
bioconversion ratio, therefore, microbial bioconversion of dietary polyphenols cannot be 368 
generalized. In fact, it is important to underline the great dispersion observed in the 369 
concentration of some phenolic metabolites (Table 4) that was likely due to the large 370 
interindividual variability in human microbiota, which could condition the phenolic metabolite 371 
production. Multiple factors such as age, diet, intestinal health, etc, might influence the 372 
composition of human microbiota (Cerdá, Tomás-Barberán & Espín, 2005; Roowi, Stalmach, 373 
Mullen, Lean, Edwards And & Crozier, 2010). Figure 3 illustrates this fact. Herein, a 374 
representative example corresponding to the interindividual differences in the production of two 375 
hydroxyphenyl acetic acids by gut microbiota can be seen. Therefore, different kinetics of the 376 
polyphenol catabolism may contribute to the interindividual variability in the metabolite profiles 377 
observed at specific sampling times. However, a large number of samples might be necessary to 378 
evidence greater differences between the essayed extracts.  379 
 380 
4. Conclusions 381 
 382 
LLE-GC-EI-MS has been proved to be useful for the characterization and quantification of 383 
phenolic metabolites from degradation of dietary polyphenols by faecal microbiota, in particular 384 
of grape seed flavan-3-ols. In addition, we have found that gut microbiota have preference for 385 
flavan-3-ol monomers than for procyanidin oligomers. However, large interindividual 386 
differences in the bioconversion rate have been also noticed. Future works will be carried out 387 
applying this LLE-GC-EI-MS methodology in intervention studies involving wine consumption 388 
by a large and representative number of individuals.  389 
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  535 
536 
FIGURE CAPTIONS 537 
 538 
Figure 1. Example showing the chromatograms corresponding to the mixture of silylated 539 
phenolic standards (1a) and to the phenolic metabolites identified in a faecal sample incubated 540 
with the whole grape extract (GSE) and collected after 30 minutes of incubation (1b). Peaks 541 
identification as in Table 1. 542 
 543 
Figure 2.  Dendrogram resulting from applying cluster analysis to the data corresponding to the 544 
concentration of phenolic metabolites analyzed in the faecal samples after the incubation with 545 
the different polyphenolic extracts.  Samples are identified by a code formed by the type of 546 
extract essayed (GSE: commercial extract of grape seed, GSE-O: oligomeric fraction of 547 
procyanidins, GSE-O: monomeric fraction of procyanidin, C-S: control sample), the incubation 548 
times 30 and 600 minutes (10 hours) (00 and 10 in the diagram) and the different individuals (1, 549 
2 and 3) 550 
 551 
Figure 3. Example showing the interindividual differences in the formation of 3- 552 
hydroxyphenylacetic acid (on the left) and 4-hydroxyphenylacetic acid (on the right) in faecal 553 
samples supplemented with the monomeric fraction of the commercial polyphenolic grape seed 554 
extract after 10 hours of incubation. 555 
 556 
